Themis Medicare
Themis Medicare Share Price Chart
Themis Medicare last traded at ₹107.23 (2026-10-13). Over the past month the stock moved -19.0%, three months the stock moved +0.9%, year the stock moved -17.2%. Its closing range over 52 weeks is ₹69.72 – ₹132.40, with the latest close 19.0% below the high.
Closing prices up to 2026-10-13.
About Themis Medicare
Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products[1]
Business Overview:[1] TML is in manufacturing antiseptics, anti-tuberculosis, anti-malarial, anti-cholesterol and pain management drugs.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Themis Medicare reported sales of ₹87.00 crore (-11.2%) and net profit of ₹25.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 87.00 | -52.00 | -60.00 | 25.00 | 2.67 |
| Mar 2026 | 77.00 | 4.00 | 4.90 | 9.00 | 0.97 |
| Dec 2025 | 90.00 | 10.00 | 11.00 | 10.00 | 1.10 |
| Sep 2025 | 78.00 | -3.00 | -4.00 | -4.00 | -0.39 |
| Jun 2025 | 98.00 | -10.00 | -10.00 | -14.00 | -1.54 |
| Mar 2025 | 72.00 | -8.00 | -11.00 | -10.00 | -1.05 |
| Dec 2024 | 94.00 | 6.00 | 6.00 | 1.00 | 0.06 |
| Sep 2024 | 117.00 | 17.00 | 15.00 | 14.00 | 1.55 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +11.4% | +13.3% | -26.5% | -20.3% | -33.3% | -4.3% | +6.9% | -11.2% |
| Operating profit growth | +41.7% | -25.0% | -188.9% | -134.5% | -117.6% | +66.7% | – | – |
| Net profit growth | +27.3% | -85.7% | -242.9% | -156.0% | -128.6% | +900.0% | – | – |
| EPS growth | +26.0% | -92.5% | -245.8% | -157.5% | -125.2% | +1733.3% | – | – |
| OPM % | 15.0% | 6.0% | -11.0% | -10.0% | -4.0% | 11.0% | 4.9% | -60.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Themis Medicare reported sales of ₹342.00 crore (-15.8%) and net profit of ₹1.00 crore (-96.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 342.00 | 0.00 | 0.00 | 1.00 | 0.12 |
| Mar 2025 | 406.00 | 49.00 | 12.00 | 30.00 | 3.24 |
| Mar 2024 | 382.00 | 52.00 | 13.00 | 44.00 | 4.73 |
| Mar 2023 | 354.00 | 67.00 | 19.00 | 57.00 | 6.18 |
| Mar 2022 | 395.00 | 96.00 | 24.00 | 73.00 | 7.92 |
| Mar 2021 | 231.00 | 49.00 | 21.00 | 36.00 | 3.88 |
| Mar 2020 | 202.00 | 36.00 | 18.00 | 25.00 | 2.70 |
| Mar 2019 | 184.00 | 2.00 | 1.00 | -11.00 | -1.17 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -12.4% | +9.8% | +14.4% | +71.0% | -10.4% | +7.9% | +6.3% | -15.8% |
| Operating profit growth | -92.0% | +1700.0% | +36.1% | +95.9% | -30.2% | -22.4% | -5.8% | -100.0% |
| Net profit growth | -200.0% | – | +44.0% | +102.8% | -21.9% | -22.8% | -31.8% | -96.7% |
| EPS growth | -195.1% | – | +43.7% | +104.1% | -22.0% | -23.5% | -31.5% | -96.3% |
| OPM % | 1.0% | 18.0% | 21.0% | 24.0% | 19.0% | 13.0% | 12.0% | 0.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Themis Medicare.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Themis Medicare.
Frequently Asked Questions
What is the share price of Themis Medicare today?
Themis Medicare shares were last quoted at ₹107.23 (-1.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Themis Medicare?
Themis Medicare has a price-to-earnings (P/E) ratio of 26.84 and a price-to-book (P/B) ratio of 2.56. The industry P/E is 53.33.
What is the 52-week high and low of Themis Medicare?
The 52-week high of Themis Medicare is ₹147.00 and the 52-week low is ₹65.00.
What is the market cap of Themis Medicare?
The market capitalisation of Themis Medicare is about ₹1,072.97 crore.
How did Themis Medicare perform in its latest quarterly results?
In the latest quarter (Jun 2026), Themis Medicare reported sales of ₹87.00 crore (-11.2%) and net profit of ₹25.00 crore, compared with the same quarter last year.
Is Themis Medicare a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Themis Medicare has a 3-year ROE of 6.00%, 3-year profit growth of -69.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Themis Medicare?
Promoters hold about 67.10% of Themis Medicare.
Which sector does Themis Medicare belong to?
Themis Medicare belongs to the Pharmaceuticals & Drugs sector.